表紙:アテレクトミーデバイスの世界市場:タイプ(方向性、回転性、軌道性、レーザー)、地域別 - 市場規模、シェア、動向分析 2019年~2026年
市場調査レポート
商品コード
490501

アテレクトミーデバイスの世界市場:タイプ(方向性、回転性、軌道性、レーザー)、地域別 - 市場規模、シェア、動向分析 2019年~2026年

Atherectomy Devices Market Size, Share & Trends Analysis by Type (Directional Atherectomy, Rotational Atherectomy, Orbital Atherectomy, Laser Atherectomy), by Regions, and Segment Forecasts, 2019 - 2026

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 120 Pages | 納期: 2-10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.50円
アテレクトミーデバイスの世界市場:タイプ(方向性、回転性、軌道性、レーザー)、地域別 - 市場規模、シェア、動向分析 2019年~2026年
出版日: 2019年09月04日
発行: Grand View Research, Inc.
ページ情報: 英文 120 Pages
納期: 2-10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のアテレクトミーデバイス市場は、2019年から2026年にかけて7.0%のCAGRで推移し、2026年までに9億5,780万米ドル規模の市場に成長すると予測されています。末梢動脈疾患などの適応疾患の罹患率の急上昇によって、アテレクトミーデバイスの需要が高まる見通しです。

当レポートでは、世界のアテレクトミーデバイス市場を調査し、市場の概要、タイプ・地域別の市場規模の推移と予測、市場シェア、市場の成長要因および阻害要因の分析、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 調査方法と範囲

  • 市場区分と範囲
  • 調査方法
  • 情報調達
  • データ分析
  • 市場構成と検証
  • モデル詳細
  • 二次情報源リスト
  • 略語リスト
  • 調査目的

第2章 エグゼクティブサマリー

  • 市場の見通し
  • セグメントの見通し

第3章 市場変数・動向・範囲

  • 市場の見通し
  • 市場区分
  • 浸透と成長の見通しのマッピング
  • 規制の枠組みと償還シナリオ
  • 市場力学
  • ビジネス環境分析ツール

第4章 世界のアテレクトミーデバイス市場の分析:タイプ別

  • 市場シェアの分析:タイプ別(実績値・予測値)
  • セグメントダッシュボード
  • 市場規模の推移と予測:タイプ別
    • 方向性
    • 回転性
    • 機動性
    • レーザー

第5章 世界のアテレクトミーデバイス市場の分析:地域別

  • 市場シェア分析:地域別(実績値・予測値)
  • セグメントダッシュボード
  • 地域市場のスナップショット
  • 企業一覧
  • SWOT分析:地域別
  • 市場規模の推移と予測:地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ

第6章 競合分析

  • 主要市場参加者別最近の開発と影響分析
  • 戦略的フレームワーク/競争の分類(主要な革新者、市場リーダー、新興企業)
  • ベンダー情勢
  • 企業プロファイル
    • Boston Scientific Corporation
    • Cardiovascular Systems Inc.
    • Medtronic plc.
    • Spectranetics
    • VOLCANO CORPORATION
    • Avinger Inc.
    • KONINKLIJKE PHILIPS N.V
    • Straub Medical AG
    • ST. JUDE MEDICAL
    • Bard Peripheral Vascular
    • CARDINAL HEALTH (CORDIS)
    • TERUMO MEDICAL CORPORATION

第7章 推奨事項

図表

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 List of abbreviation
  • TABLE 3 List of players in North America
  • TABLE 4 List of players in Europe
  • TABLE 5 List of players in Asia Pacific
  • TABLE 6 North America atherectomy devices, by country, 2015 - 2026 (USD Million)
  • TABLE 7 North America atherectomy devices market, by type, 2015 - 2026 (USD Million)
  • TABLE 8 U.S. atherectomy devices market, by type, 2015 - 2026 (USD Million)
  • TABLE 9 Canada atherectomy devices market, by type, 2015 - 2026 (USD Million)
  • TABLE 10 Europe atherectomy devices market, by country, 2015 - 2026 (USD Million)
  • TABLE 11 Europe atherectomy devices market, by type, 2015 - 2026 (USD Million)
  • TABLE 12 UK atherectomy devices market, by type, 2015 - 2026 (USD Million)
  • TABLE 13 Germany atherectomy devices market, by type, 2015 - 2026 (USD Million)
  • TABLE 14 France atherectomy devices market, by type, 2015 - 2026 (USD Million)
  • TABLE 15 Italy atherectomy devices market, by type, 2015 - 2026 (USD Million)
  • TABLE 16 Asia Pacific atherectomy devices market, by country, 2015 - 2026 (USD Million)
  • TABLE 17 Asia Pacific atherectomy devices market, by type, 2015 - 2026 (USD Million)
  • TABLE 18 Japan atherectomy devices market, by type, 2015 - 2026 (USD Million)
  • TABLE 19 China atherectomy devices market, by type, 2015 - 2026 (USD Million)
  • TABLE 20 Latin America atherectomy devices market, by country, 2015 - 2026 (USD Million)
  • TABLE 21 Latin America atherectomy devices market, by type, 2015 - 2026 (USD Million)
  • TABLE 22 Brazil atherectomy devices market, by type, 2015 - 2026 (USD Million)
  • TABLE 23 Middle East & Africa atherectomy devices market, by country, 2015 - 2026 (USD Million)
  • TABLE 24 Middle East & Africa atherectomy devices market, by type, 2015 - 2026 (USD Million)
  • TABLE 25 South Africa atherectomy devices market, by type, 2015 - 2026 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain-based sizing &forecasting
  • FIG. 6 QFD modeling for market share assessment
  • FIG. 7 Market summary
  • FIG. 8 Market trends & outlook
  • FIG. 9 Market segmentation & scope
  • FIG. 10 Market driver relevance analysis (Current & future impact)
  • FIG. 11 Prevalence of PAD (%)
  • FIG. 12 Volume of minimally invasive surgeries, 2005 - 2015 (Thousands)
  • FIG. 13 Market restraint relevance analysis (Current &future impact)
  • FIG. 14 Penetration & growth prospect mapping
  • FIG. 15 Atherectomy devices market - PESTLE analysis
  • FIG. 16 Porter's Five Forces Analysis
  • FIG. 17 Atherectomy devices: Heat map analysis
  • FIG. 18 Atherectomy devices market type outlook key takeaways
  • FIG. 19 Atherectomy devices: Type movement analysis
  • FIG. 20 Global directional atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 21 Above knee atherosclerosis
  • FIG. 22 Below knee atherosclerosis
  • FIG. 23 Global rotational atherectomy market, 2015 - 2026 (USD Million)
  • FIG. 24 Global orbital atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 25 Global laser atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 26 Atherectomy devices reional market share analysis, 2018 & 2026
  • FIG. 27 Atherectomy devices regional market: Segment dashboard
  • FIG. 28 Regional market snapshot
  • FIG. 29 North America atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 30 U.S. atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 31 Canada atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 32 Europe atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 33 UK atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 34 Germany atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 35 France atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 36 Italy atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 37 Asia Pacific atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 38 China atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 39 Japan atherectomy devices Market, 2015 - 2026 (USD Million)
  • FIG. 40 Latin America atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 41 Brazil atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 42 MEA atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 43 South Africa atherectomy devices market, 2015 - 2026 (USD Million)
  • FIG. 44 Strategy framework
  • FIG. 45 Strategy framework / Competition categorization
  • FIG. 46 Company market position analysis (service portfolio, strategic initiatives, geographic presence)
目次
Product Code: GVR-1-68038-416-1

The global atherectomy devices market size is expected to reach USD 957.8 million by 2026, based on a new report by Grand View Research, Inc. The market is projected to register a CAGR of 7.0% over the forecast period. The demand for atherectomy devices market is anticipated to boost over the forecast period due to rapidly rising incidence of target diseases such as peripheral artery disease. Favorable patient outcomes with minimally invasive procedures is also driving demand of atherectomy devices for peripheral vascular interventions.

New technologies and product approvals are expected to boost the market for orbital and laser atherectomy devices over the forecast period. For instance, in July 2018, Cardiovascular Systems, Inc. (CSI) signed an agreement with Aerolase Corp. to co-develop a new laser atherectomy device. The agreement gave CSI an opportunity to leverage Aerolase's FDA cleared proprietary laser technology. The new laser atherectomy system will be used for treating multiple forms of peripheral arterial diseases

Further Key Findings From the Study Suggest:

  • In 2018, the directional atherectomy segment held the largest market share owing to their capability of collecting the shaved plaque in a collecting space, which reduces the risk of barotrauma, dissection, and neointimal hyperplasia.
  • Laser atherectomy devices is expected to the fastest growing segment over the next 8 years. Laser technique is perceived as to have more precision in plaque removal and cause fewer complications. It is also believed to result in lesser incidence of restenosis.
  • Geographically, North America held the largest market share in 2018 and is expected to maintain its position during the forecast period. A high prevalence of Peripheral Artery Diseases (PAD) in this region is one of the key reasons for high demand of atherectomy. Almost 8.5 million people suffer from PAD in the U.S., resulting in an annual economic burden of nearly USD 160 million.
  • Asia Pacific is anticipated to observe the fastest growth over the coming years. Improving economic conditions leading to increasing prevalence of lifestyle diseases, especially cardiovascular and peripheral, is the key reason for this growth.

Some of the key industry contributors are: Boston Scientific Corporation, Cardiovascular Systems Inc., Medtronic (Covidien), Spectranetics, VOLCANO CORPORATION, Avinger Inc., Koninklijke Philips N.V., Straub Medical AG, ST. JUDE MEDICAL, BARD Peripheral Vascular, Cardinal Health (Cordis), and Terumo IS.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Type
    • 1.1.2 Regional scope
    • 1.1.3 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased database
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity flow analysis
      • 1.6.1.1 Approach 1: Commodity flow approach
    • 1.6.2 Volume price analysis
      • 1.6.2.1 Approach 2: Volume price analysis
  • 1.7 List of Secondary Sources
  • 1.8 List of Abbreviations
  • 1.9 Objectives
    • 1.9.1 Objective 1
    • 1.9.2 Objective 2

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Lineage outlook
    • 3.1.1 Parent market outlook
  • 3.2 Market Segmentation
    • 3.2.1 Analysis
  • 3.3 Market Dynamics
    • 3.3.1 Market driver analysis
      • 3.3.1.1 Increasing prevelance of target diseases
      • 3.3.1.2 Preference to minimally invasive procedures
    • 3.3.2 Market restraint analysis
      • 3.3.2.1 Lack of level 1 evidence for atherectomy
      • 3.3.2.2 Lack of technical training for the procedures
    • 3.3.3 Industry opportunities
  • 3.4 Penetration & Growth Prospect Mapping
    • 3.4.1 Penetration & growth prospect mapping analysis
  • 3.5 Business Environment Analysis Tools
    • 3.5.1 Porter's five forces analysis
    • 3.5.2 Pestel analysis
    • 3.5.3 Major deals & strategic alliances analysis
      • 3.5.3.1 Mergers & acquisitions and joint ventures
      • 3.5.3.2 Licensing & partnerships and technology collaborations

Chapter 4 Atherectomy Devices Market: Type Analysis

  • 4.1 Atherectomy Devices Type Market Share Analysis, 2018 & 2026
  • 4.2 Atherectomy Devices Type Market: Segment Dashboard
  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Type Segment
    • 4.3.1 Directional atherectomy
      • 4.3.1.1 Directional atherectomy devices market, 2015 - 2026 (USD Million)
    • 4.3.2 Rotational atherectomy
      • 4.3.2.1 Rotational atherectomy devices market, 2015 - 2026 (USD Million)
    • 4.3.3 Orbital atherectomy
      • 4.3.3.1 Orbital atherectomy devices market, 2015 - 2026 (USD Million)
    • 4.3.4 Laser atherectomy
      • 4.3.4.1 Laser atherectomy devices market, 2015 - 2026 (USD Million)

Chapter 5 Atherectomy Devices Market: Regional Analysis

  • 5.1 Atherectomy Devices Regional Market Share Analysis, 2018 & 2026
  • 5.2 Atherectomy Devices-Regional Market: Segment Dashboard
  • 5.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
  • 5.4 List of Players at Regional Level
    • 5.4.1 North America
    • 5.4.2 Europe
    • 5.4.3 Asia Pacific
  • 5.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 5.5.1 North America
    • 5.5.2 Europe
    • 5.5.3 Asia Pacific
    • 5.5.4 Latin America
    • 5.5.5 MEA
  • 5.6 Market Size, & Forecasts, and Trend Analysis, 2015 to 2026
    • 5.6.1 North America
      • 5.6.1.1 North America Atherectomy Devices market, 2015 - 2026 (USD Million)
      • 5.6.1.2 U.S.
      • 5.6.1.2.1 Regulatory & reimbursement scenario
      • 5.6.1.2.2 U.S. Atherectomy Devices market, 2015 - 2026 (USD Million)
      • 5.6.1.3 Canada
      • 5.6.1.3.1 Regulatory & reimbursement scenario
      • 5.6.1.3.2 Canada Atherectomy Devices market, 2015- 2026 (USD Million)
    • 5.6.2 Europe
      • 5.6.2.1 Europe Atherectomy Devices market, 2015 - 2026 (USD Million)
      • 5.6.2.2 UK
      • 5.6.2.2.1 Regulatory & reimbursement scenario
      • 5.6.2.2.2 UK Atherectomy Devices market, 2015- 2026 (USD Million)
      • 5.6.2.3 Germany
      • 5.6.2.3.1 Regulatory & reimbursement scenario
      • 5.6.2.3.2 Germany Atherectomy Devices market, 2015 - 2026 (USD Million)
      • 5.6.2.4 France
      • 5.6.2.4.1 Regulatory & reimbursement scenario
      • 5.6.2.4.2 France Atherectomy Devices market, 2015 - 2026 (USD Million)
      • 5.6.2.5 Italy
      • 5.6.2.5.1 Regulatory & reimbursement scenario
      • 5.6.2.5.2 Italy Atherectomy Devices market, 2015 - 2026 (USD Million)
    • 5.6.3 Asia Pacific
      • 5.6.3.1 Asia Pacific Atherectomy Devices market, 2015 - 2026 (USD Million)
      • 5.6.3.2 Japan
      • 5.6.3.2.1 Regulatory & reimbursement scenario
      • 5.6.3.2.2 Japan Atherectomy Devices market, 2015 - 2026 (USD Million)
      • 5.6.3.3 China
      • 5.6.3.3.1 Regulatory & reimbursement scenario
      • 5.6.3.3.2 China Atherectomy Devices market, 2015 - 2026 (USD Million)
    • 5.6.4 Latin America
      • 5.6.4.1 Latin America Atherectomy Devices market, 2015 - 2026 (USD Million)
      • 5.6.4.2 Brazil
      • 5.6.4.2.1 Regulatory & reimbursement scenario
      • 5.6.4.2.2 Brazil Atherectomy Devices market, 2015 - 2026 (USD Million)
    • 5.6.5 Middle East and Africa
      • 5.6.5.1 MEA Atherectomy Devices market, 2015- 2026 (USD Million)
      • 5.6.5.2 South Africa
      • 5.6.5.2.1 Regulatory & reimbursement scenario
      • 5.6.5.2.2 South Africa Atherectomy Devices market, 2015 - 2026 (USD Million)

Chapter 6 Competitive Analysis

  • 6.1 Recent developments & impact analysis, by key market participants
  • 6.2 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, Emerging players)
  • 6.3 Vendor Landscape
    • 6.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
  • 6.4 Company Profiles
    • 6.4.1 Boston Scientific Corporation
      • 6.4.1.1 Company overview
      • 6.4.1.2 Financial performance
      • 6.4.1.3 Product benchmarking
      • 6.4.1.4 Strategic initiatives
      • 6.4.1.5 SWOT analysis
    • 6.4.2 Cardiovascular Systems Inc.
      • 6.4.2.1 Company overview
      • 6.4.2.2 Financial performance
      • 6.4.2.3 Product benchmarking
      • 6.4.2.4 Strategic initiatives
      • 6.4.2.5 SWOT analysis
    • 6.4.3 Medtronic plc.
      • 6.4.3.1 Company overview
      • 6.4.3.2 Financial performance
      • 6.4.3.3 Product benchmarking
      • 6.4.3.4 Strategic initiatives
      • 6.4.3.5 SWOT analysis
    • 6.4.4 Spectranetics
      • 6.4.4.1 Company overview
      • 6.4.4.2 Financial performance
      • 6.4.4.3 Product benchmarking
      • 6.4.4.4 Strategic initiatives
      • 6.4.4.5 SWOT analysis
    • 6.4.5 VOLCANO CORPORATION
      • 6.4.5.1 Company overview
      • 6.4.5.2 Financial performance
      • 6.4.5.3 Product benchmarking
      • 6.4.5.4 Strategic initiatives
      • 6.4.5.5 SWOT analysis
    • 6.4.6 Avinger Inc.
      • 6.4.6.1 Company overview
      • 6.4.6.2 Financial performance
      • 6.4.6.3 Product benchmarking
      • 6.4.6.4 Strategic initiatives
      • 6.4.6.5 SWOT analysis
    • 6.4.7 KONINKLIJKE PHILIPS N.V
      • 6.4.7.1 Company overview
      • 6.4.7.2 Financial performance
      • 6.4.7.3 Product benchmarking
      • 6.4.7.4 Strategic initiatives
      • 6.4.7.5 SWOT analysis
    • 6.4.8 Straub Medical AG
      • 6.4.8.1 Company overview
      • 6.4.8.2 Product benchmarking
      • 6.4.8.3 Financial performance
      • 6.4.8.4 Strategic initiatives
      • 6.4.8.5 SWOT Analysis
    • 6.4.9 ST. JUDE MEDICAL
      • 6.4.9.1 Company overview
      • 6.4.9.2 Product benchmarking
      • 6.4.9.3 Financial performance
      • 6.4.9.4 Strategic initiatives
      • 6.4.9.5 SWOT analysis
    • 6.4.10 Bard Peripheral Vascular
      • 6.4.10.1 Company overview
      • 6.4.10.2 Product benchmarking
      • 6.4.10.3 Financial performance
      • 6.4.10.4 Strategic initiatives
      • 6.4.10.5.SWOT Analysis
    • 6.4.11 CARDINAL HEALTH (CORDIS)
      • 6.4.11.1 Company overview
      • 6.4.11.2 Product benchmarking
      • 6.4.11.3 Financial performance
      • 6.4.11.4 Strategic initiatives
      • 6.4.11.5.SWOT Analysis
    • 6.4.12 TERUMO MEDICAL CORPORATION
      • 6.4.12.1 Company overview
      • 6.4.12.2 Product benchmarking
      • 6.4.12.3 Financial performance
      • 6.4.12.4 Strategic initiatives
      • 6.4.12.5.SWOT Analysis

Chapter 7 Recommendations